CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
about
Chronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationMild cognitive impairment and its management in older peopleExploring Biomarkers for Alzheimer's DiseaseBiomarkers for cognitive impairment and dementia in elderly people.Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.Olfactory impairment in presymptomatic Alzheimer's disease.Cerebrospinal fluid biomarkers in mild cognitive impairment and dementiaEstimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directionsAmyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis).Mild cognitive impairment: The dilemma.Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time.Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.Biomarkers in chronic adult hydrocephalus.CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.Small RNA Library Construction for Exosomal RNA from Biological Samples for the Ion Torrent PGM™ and Ion S5™ System.Detection of brain injury by fatty acid-binding proteins.Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.Hippocampal Injections of Oligomeric Amyloid β-peptide (1-42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway.Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.DNA methylation in repetitive elements and Alzheimer diseaseBiomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer's disease and mild cognitive impairmentCerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome.Targeting Beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer's disease.Molecular biomarkers of neurodegeneration.Quantitative Analysis of Exosomal miRNA via qPCR and Digital PCR.Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD.Is Huntington's disease a tauopathy?Macular Thickness in Subjective Memory Complaints and Mild Cognitive Impairment: A Non-Invasive Biomarker.Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile.Tau as a biomarker of neurodegenerative diseases.Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion.Neurocognitive and Behavioral Indexes for Identifying the Amnestic Subtypes of Mild Cognitive Impairment.
P2860
Q26748974-9110FA6E-39D2-4A72-AD8C-8B4EBB669B4BQ26822601-0C08EAC6-D516-4A14-B525-AF2EDA1A1B50Q28079218-9593BEE4-DF64-478C-B334-33E4219722D1Q30370745-ED214803-1450-48F4-A350-8A5AA835EEFDQ31108280-02C2666D-61C4-4C23-BFB4-4EF28EB5B62EQ33590723-19981F19-3AB9-4DDE-9DE5-79E2EBBDD80BQ33713286-BCCD2400-5FB8-4BB1-BA10-3654C41D9C03Q33802937-41D488EF-DC8C-4CA1-AD12-833446A38F5DQ33936708-FC312F07-8428-482B-AB0C-472B083F0474Q34135724-637CD2BD-A561-4123-86E1-7560428EE31FQ34479422-A2C1AEB7-4821-4D1D-8857-47D2E65D9CD5Q34572010-8780FB7D-B4C3-4E42-AE84-F25EBD5A46D9Q34728483-89D5D55C-6F70-4CE3-8678-9FC5644A2515Q35004793-8800A34E-D488-46F5-8A96-68735D3012F8Q35029099-9428CD7C-1B22-45AC-9EAA-F4D29CD2A88BQ35101048-174D5DAC-6287-4FA0-BF43-EFD7C8248000Q35114771-9A50D84F-1328-45FE-A6A0-E7D5F512829CQ36012068-CE33E9BE-D16D-479E-B123-020BD62E8C56Q36220441-30C34A0B-C230-4E05-864F-F9F62561E7F3Q36275438-D989B218-114D-420E-8862-128964899E44Q36382217-EC5D6CBD-21A3-42A3-A47B-2DA6D99AA4C7Q36449089-0763EBE5-43EE-410F-A59C-D0D0FFA9D9C6Q36607324-EB968587-34F2-4F0F-8994-384269D93F89Q36725676-D7BEDD05-49C2-42A3-89B8-9BB3471DF8FDQ37091491-21E6D7A6-471D-4F2E-AAA8-D5BBBF4D5763Q37273675-8EECEB73-B92F-4D9F-A66D-D236FFBBD085Q37381205-D3694AD2-017A-429E-B46E-BEE8CFD014BBQ37524486-8AF54AD9-9178-4E4E-85C8-6CB9AFB277C7Q37680840-BD8ADE92-C9FF-478E-84F4-9FF05642BA77Q37741452-E6D97318-FC42-44D6-A0C6-8D40855A4B20Q37980146-CB674F4E-00B5-460D-A14E-09804956E8DCQ38154930-C52C92A9-DF2C-490F-A673-61CF030EE4DDQ38376856-6CBC6DDE-4379-4B52-B2DB-5708C3F3F8BBQ38493709-A6278B55-2615-43BE-98FC-742C5373C59CQ38771048-6FC531CD-E485-47D7-860C-96BAC3383227Q38785922-45AA16EE-8D50-4179-BD66-4BC802222213Q39521884-5A669CD2-CF44-427A-9A6C-5935AA2811E3Q40065021-36B0B430-120B-46FE-9A81-877CEF79C282Q40183680-1C3B4393-CA37-46E7-9B54-D4B2E845B7FDQ42062975-307775A2-785D-4BAB-B654-EFC8DA1E8892
P2860
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
@ast
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
@en
type
label
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
@ast
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
@en
prefLabel
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
@ast
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
@en
P1476
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
@en
P2093
Niels Andreasen
P304
P356
10.1016/J.CLINEURO.2004.10.011
P50
P577
2005-04-01T00:00:00Z